NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/04/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization657.68 mln
Float120 mln
Earnings Date11/09/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.56
Highly reliable
1-Year Forecast
9.33
Transformational upside
Relative Strength
96
/ 100
Top performer
Debt / Equity
-1.04
Negative equity
Pre-Tax Margin
-145%
Severely loss-making
Business Description
Aquestive Therapeutics is a US-based pharmaceutical company that develops and sells medicines in film-based formats, making treatments easier to take for patients with conditions such as epilepsy, opioid dependence, and ADHD. The company has several products already on the market, including treatments for seizures and allergic reactions, alongside a growing pipeline of new therapies currently in clinical trials. Founded in 2004 and based in Warren, New Jersey, Aquestive also licenses its proprietary film delivery technology to other drug makers targeting disorders of the central nervous system.
